- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Michael Kolodziej Discusses the Role of Commercial Payers in Value-Based Care
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.
Transcript
Are commercial payers beginning to have a bigger presence in value-based care?
The issue with commercial payers is that they’re very interesting in doing things that are easy for them administratively. I don’t think they’re going to embrace [Oncology Care Model]. It’s just too complicated. It’s just too much work. I believe pathways are going to be—and you can certainly define pathways as value-based care. In fact, there is no definition of value-based care. There’s a broad spectrum of what constitutes value-based care, and pathways clearly exists within that spectrum.
I think payers will all adopt some sort of “value-based care program.” It might not be what the folks at OncoCloud consider value-based care, but it is by the strictest sense of the word a model of care.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
